SERPINA1 and chronic obstructive pulmonary disease: In addition, genetic data usage like alpha-1 antitrypsin (AAT) deficiency status in treatment strategies allows a personalized approach to managing COPD, such as augmentation therapy with AAT replacement for AAT-deficient individuals [49].